Redx will become a key upcoming player in IPF treatment with FDA’s ODD for zelasudil: GlobalData Read more
Zydus announces Phase IV EVIDENCES-XI trial to generate RWE of Saroglitazar Mg in NAFLD patients with comorbidities Read more
Zydus gets Orphan Drug Designation from USFDA for ZYIL1 to treat Cryopyrin Associated Periodic Syndrome Read more
US FDA grants Orphan Drug Designation to BCMA CAR-T cell therapy co-developed by Innovent Biologics and IASO Bio Read more
Theseus Pharmaceuticals receives US FDA Orphan Drug Designation for THE-630 to treat Advanced Gastrointestinal Stromal Tumours (GIST) Read more
US FDA grants Orphan Drug Designation to Zydus’ Saroglitazar for primary biliary cholangitis treatment Read more